Key facts
- Notable investors include Capital Q Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for NUR (Los Angeles)
- ·The full record, as it builds
Funding rounds
No funding rounds for NUR (Los Angeles) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NUR (Los Angeles)
Developer and manufacturer of protein products intended for daily hydration. The company offers an alternative to traditional powder-based supplements that utilize fermented Beta-Lactoglobulin (BLG), rich in essential amino acids, particularly leucine, which plays an essential role in muscle protein synthesis, enabling its customers to get protein mixes designed for use in standard water bottles.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Los Angeles, CA, United States
- Founded
- 2025
- Employees
- 6
- Website
- nurprotein.com/
- Ownership
- Privately Held (backing)
NUR (Los Angeles) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NUR (Los Angeles) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NUR (Los Angeles) in its N-PORT filings yet. We sweep new filings monthly.